CGB Mission

National Human Genome Research Institute

National Institutes of Health
U.S. Department of Health and Human Services


Cancer Genetics Branch Mission

The Cancer Genetics Branch (CGB) is part of the National Human Genome Research Institute, one of the 27 Institutes and Centers that constitute the National Institutes of Health. CGB was founded in 1993 and is one of several research branches within the Institute's Intramural Research Program that develops and utilizes state-of-the-art genomic-based technologies. The Branch applies these advances to cancer-related questions of public health concern. The primary focus of CGB investigators is to identify the genetic contribution to the processes of cancer susceptibility, tumor initiation and progression, treatment response, and long-term outcomes.

Specifically, the program:

In summary, the scientists of the Cancer Genetics Branch work in a highly collaborative and multi-disciplinary setting to answer questions regarding the causes, growth patterns, and treatment responses associated with cancer. We are interested in defining and understanding the functional role of proteins involved in all phases of tumor development and growth for a variety of tumor types. Our long-term goal is to see our findings translated to advances in diagnosis and treatment. Finally, we utilize state of the art approaches in all phases of our work and we seek to develop and contribute advances in genomic technology to all fields of human health and biology.

Top of page

Posted: January 24, 2013